All Time Service Available Call Girls Marine Drive 📳 9820252231 For 18+ VIP C...
MTM Presentation
1. Pharmacists Improving Care and Reducing Costs image001 logo
2.
3.
4. Medication-Related Problems $$$$ Increased Costs to the Health Care System $$$$ Increased Costs to Employers $$$$ Increased Insurance Premiums or Direct Costs dd_senior_drug_caution images
5.
6.
7. Where Are You Spending Your Health Care Dollars? Kaiser Family Foundation, 2007. http://www.kff.org/insurance/index.cfm
20. Clinical Outcomes of MTM The Asheville Project - Asthma Improved Asthma control sustained over 5 years Bunting BA, Cranor CW. The Asheville Project: long-term clinical, humanistic, and economic outcomes of a community-based medication therapy management program for asthma. J Am Pharm Assoc. 2006;46:133 – 47.
21. Clinical Outcomes of MTM The Asheville Project - Diabetes A1C < 7% Total Cholesterol < 200 mg/dl LDL < 100 mg/dl Cranor CW, Bunting BA, Christensen DB. The Asheville Project: long-term clinical and economic outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc. 2003;43:173 – 84.
22. Clinical Outcomes of MTM [customize this slide to meet the needs of your target audience - may include clinical outcomes from your practice or other specific clinical outcomes of interest to your audience]
23.
24. Total costs $9,035 $8,913 $8,802 $7,490 (N = 63) Year 3 Savings Per Patient from Projected Costs $6,250 from Baseline Costs $1,545 Yr 1 Projected $10,390 Year 3 Projected $13,740 Baseline $9,035 Year 2 Projected $11,948 APhA Foundation Patient Self-Management Program for Diabetes – Economic Impact Baseline, Years 1, 2, and 3 Compared With Projected Costs* Data provided by the APhA Foundation. *Projected increases based on multiple sources, not according to the ADA. Total medical expenditures incurred by people with diabetes were $13,243 per capita in 2002, compared with $2,560 for people without diabetes.
25. Economic Outcomes of MTM From Our Practice [ customize this slide to meet the needs of your target audience –include economic outcomes from analysis conducted in your own practice that may be of interest to your target audience]
26.
27.
28.
29.
30. APhA Survey Findings of Health Care Measures/Needs Addressed by MTM Services Schommer JC, Planas LG, Johnson KA, et al. Pharmacist-provided medication therapy management (part 2): payer perspectives in 2007 . J Am Pharm Assoc. 2008;48:478 –86.
31. APhA Survey Findings of Impact of MTM on Future Outcomes Schommer JC, Planas LG, Johnson KA, et al. Pharmacist-provided medication therapy management (part 2): payer perspectives in 2007 . J Am Pharm Assoc. 2008;48:478 –86.
32.
33.
34.
35.
36.
37.
38.
39.
40. Clinical Outcomes of MTM Asthma Patients Bunting BA, Cranor CW. The Asheville Project: long-term clinical, humanistic, and economic outcomes of a community-based medication therapy management program for asthma. J Am Pharm Assoc. 2006;46:133–47. Link to full text: http://japha.metapress.com/link.asp?id=vr845p3l32384830
41. Economic Outcomes of MTM Decrease in yearly Rx cost to health plan (N = 7 patients) Rx cost to patient/year (N = 7 patients) McCarthy RA, Bennett MS, Green CG. Abstract: Medication therapy management services for a non-Medicare population: short-term assessment of economic, clinical, and humanistic outcomes. http://www.glprc.com/Abstracts/rptAbstracts%202006.pdf.
![Medication Therapy Management, LLC ,[object Object],[object Object],[object Object]](data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7)